Eli Lilly gets nod to sell weight-loss drug in Hong Kong by year-end - report
Eli Lilly (NYSE:LLY) received approval from the Hong Kong government to launch its weight-loss drug—Mounjaro, with sales ...
Reuters on MSN17d
Eli Lilly Gets Nod to Launch Weight-Loss Drug in Hong Kong - Bloomberg News
The drugmaker has received approval from the Hong Kong government to sell its tirzepatide injections — branded as Mounjaro — ...
Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report
Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of ...
Eli Lilly tells Bloomberg approval received to launch Mounjaro in Hong Kong
Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the ...
pharmaphorum1d
Britain will be first to get new Mounjaro device, says Lilly
The agency has approved a four-dose version of the drug, called Mounjaro KwikPen, which provides a month’s course of GLP-1 and GIP agonist tirzepatide. Great Britain will be the first major ...
Eli Lilly & Co: Buy Rating Affirmed Amidst U.S. Market Challenges and International Growth Potential
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target ...
Seeking Alpha17d
Eli Lilly gets nod to sell weight-loss drug in Hong Kong by year-end - report
The company got approval to sell its tirzepatide injections—branded as Mounjaro—in a device called Kwikpen. Mounjaro is designed for long-term weight management and the treatment of type 2 ...